Literature DB >> 20483927

How New Zealand has contained expenditure on drugs.

Jacqueline Cumming1, Nicholas Mays, Jacob Daubé.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20483927     DOI： 10.1136/bmj.c2441

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar.

Authors:  Ahmed Awaisu; Nadir Kheir; Mohamed Izham Mohamed Ibrahim; Maguy El-Hajj; Huda Hazi; Nada Khudair; Raja Barazi
Journal:  Int J Clin Pharm       Date:  2014-02-15

2.  Ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary.

Authors:  Robin Gauld
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

3.  The insulin dilemma in resource-limited countries. A way forward?

Authors:  G V Gill; J S Yudkin; H Keen; D Beran
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

4.  A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.

Authors:  Rajan Ragupathy; Katri Aaltonen; June Tordoff; Pauline Norris; David Reith
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

5.  A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand.

Authors:  Zaheer-Ud-Din Babar; Piyush Grover; Rachael Butler; Lynne Bye; Janie Sheridan
Journal:  BMJ Open       Date:  2012-03-28       Impact factor: 2.692

Review 6.  A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development.

Authors:  Lianne Barnieh; Fiona Clement; Anthony Harris; Marja Blom; Cam Donaldson; Scott Klarenbach; Don Husereau; Diane Lorenzetti; Braden Manns
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

7.  Comment on "ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary" : clarification from PHARMAC: PHARMAC takes no particular distributive approach (utilitarian or otherwise).

Authors:  Scott Metcalfe; Rachel Grocott; Dilky Rasiah
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

8.  New Zealand consumers' perceptions of private insurance for pharmaceuticals.

Authors:  Rajan Ragupathy; Zaheer-Ud-Din Babar; Wasif Mirza; Mitali Daiya; Himesh Chandra; Ali Yousif; Maninder Girn
Journal:  Springerplus       Date:  2014-10-08

9.  Analgesic Medicine Utilization in Older People in New Zealand from 2005 to 2013.

Authors:  Prasad S Nishtala; Sekbong Oh; Daniel Kim; Natalie Chun; Siti Fatimah Binti Kamis; Kuan-Cia Kiu
Journal:  Drugs Real World Outcomes       Date:  2015-06

10.  Identifying priority medicines policy issues for New Zealand: a general inductive study.

Authors:  Zaheer-Ud-Din Babar; Susan Francis
Journal:  BMJ Open       Date:  2014-05-28       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.